Pricing Log in Create free account

Cyteir Therapeutics, Inc. (CYTT) vs Genelux Corporation (GNLX)

Cyteir Therapeutics, Inc. and Genelux Corporation are both Biotechnology companies. Cyteir Therapeutics, Inc. and Genelux Corporation are of similar size ($112.2M and $108.7M). Across the 9 metrics below, Cyteir Therapeutics, Inc. leads on 8 and Genelux Corporation on 1.

Valuation

Metric CYTT GNLX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 9.67 9.71
P/B 0.87 6.75 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.55 n/m 0.64
EV/Sales n/m 8.77 9.21
Earnings yield (31.23%) (35.54%) (33.15%)
Free cash flow yield (23.50%) (26.36%) (25.50%)

Profitability

Metric CYTT GNLX Biotechnology median
Gross margin 0.00% (3.42%) 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (23.80%) (177.93%) (56.36%)
Return on assets (22.70%) (121.80%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYTT GNLX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 39.35% 9.47% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CYTT GNLX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 21.89 2.39 4.72
Net debt to EBITDA 3.10 0.44 0.96

Dividend

Metric CYTT GNLX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYTT GNLX Biotechnology median
Market cap 108.72m 112.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack